As Factset Research (FDS) Valuation Rose, Dock Street Asset Management Has Upped Its Stake; New Leaf Venture Partners Decreased Its Stake in Sage Therapeutics (SAGE) by $3.26 Million as Stock Value Declined

April 22, 2018 - By Marie Mckinney

FactSet Research Systems Inc. (NYSE:FDS) Logo

Dock Street Asset Management Inc increased its stake in Factset Research (FDS) by 14.74% based on its latest 2017Q4 regulatory filing with the SEC. Dock Street Asset Management Inc bought 5,753 shares as the company’s stock rose 5.01% while stock markets declined. The institutional investor held 44,786 shares of the programming company at the end of 2017Q4, valued at $8.63 million, up from 39,033 at the end of the previous reported quarter. Dock Street Asset Management Inc who had been investing in Factset Research for a number of months, seems to be bullish on the $7.49 billion market cap company. The stock decreased 0.96% or $1.87 during the last trading session, reaching $192.58. About 365,349 shares traded or 12.84% up from the average. FactSet Research Systems Inc. (NYSE:FDS) has risen 15.57% since April 22, 2017 and is uptrending. It has outperformed by 4.02% the S&P500.

Robert Boucai decreased its stake in Sage Therapeutics Inc (SAGE) by 44.29% based on its latest 2017Q4 regulatory filing with the SEC. New Leaf Venture Partners Llc sold 19,872 shares as the company’s stock declined 6.84% with the market. The hedge fund run by Robert Boucai held 25,000 shares of the health care company at the end of 2017Q4, valued at $4.12 million, down from 44,872 at the end of the previous reported quarter. New Leaf Venture Partners Llc who had been investing in Sage Therapeutics Inc for a number of months, seems to be less bullish one the $6.78 billion market cap company. The stock decreased 12.77% or $21.66 during the last trading session, reaching $148.01. About 1.32 million shares traded or 130.95% up from the average. Sage Therapeutics, Inc. (NASDAQ:SAGE) has risen 135.95% since April 22, 2017 and is uptrending. It has outperformed by 124.40% the S&P500.

Since January 3, 2018, it had 0 insider purchases, and 6 sales for $11.84 million activity. Shares for $229,989 were sold by MCGONIGLE JAMES J on Monday, January 8. 5,675 shares were sold by Nicolelli Maurizio, worth $1.12M. $9.52 million worth of FactSet Research Systems Inc. (NYSE:FDS) shares were sold by Hale Mark J.. 1,000 shares were sold by McNulty Matthew J, worth $198,000 on Friday, January 12.

Dock Street Asset Management Inc, which manages about $409.17M and $258.34M US Long portfolio, decreased its stake in S&P Midcap 400 (IJH) by 12,155 shares to 44,878 shares, valued at $8.52M in 2017Q4, according to the filing.

Investors sentiment decreased to 0.88 in 2017 Q4. Its down 0.20, from 1.08 in 2017Q3. It turned negative, as 38 investors sold FDS shares while 127 reduced holdings. 46 funds opened positions while 99 raised stakes. 36.76 million shares or 1.32% more from 36.28 million shares in 2017Q3 were reported. Schroder Invest Management Gru has invested 0.06% in FactSet Research Systems Inc. (NYSE:FDS). 7,959 were accumulated by Oppenheimer Asset. Moreover, Teacher Retirement Systems Of Texas has 0.02% invested in FactSet Research Systems Inc. (NYSE:FDS) for 13,477 shares. Somerset Trust Com holds 0.85% or 8,864 shares. 180 were reported by Mufg Americas. Moreover, Panagora Asset Inc has 0% invested in FactSet Research Systems Inc. (NYSE:FDS). Cambridge Rech Advsr accumulated 5,435 shares. Sterling Cap Ltd Company stated it has 1,569 shares. Mai Capital Mngmt invested in 4,539 shares. Clarkston Cap Partners Limited Liability stated it has 0.08% in FactSet Research Systems Inc. (NYSE:FDS). Loomis Sayles & Ltd Partnership has invested 1.26% in FactSet Research Systems Inc. (NYSE:FDS). Bokf Na holds 9,733 shares. Sg Americas Securities Limited Com has 7,463 shares for 0.01% of their portfolio. Fiduciary Management Inc Wi stated it has 0.29% in FactSet Research Systems Inc. (NYSE:FDS). Davenport And Company Ltd Liability stated it has 0.01% of its portfolio in FactSet Research Systems Inc. (NYSE:FDS).

Among 19 analysts covering FactSet Research Systems Inc. (NYSE:FDS), 2 have Buy rating, 3 Sell and 14 Hold. Therefore 11% are positive. FactSet Research Systems Inc. had 43 analyst reports since September 22, 2015 according to SRatingsIntel. The stock of FactSet Research Systems Inc. (NYSE:FDS) has “Neutral” rating given on Tuesday, March 22 by Sterne Agee CRT. The stock has “Equal-Weight” rating by Morgan Stanley on Wednesday, March 28. Barclays Capital maintained it with “Equal-Weight” rating and $160 target in Wednesday, March 16 report. Raymond James downgraded the shares of FDS in report on Tuesday, September 27 to “Underperform” rating. The rating was initiated by Evercore on Thursday, January 7 with “Hold”. The rating was maintained by Stifel Nicolaus on Tuesday, March 27 with “Hold”. Stifel Nicolaus downgraded FactSet Research Systems Inc. (NYSE:FDS) on Wednesday, March 16 to “Hold” rating. The firm has “Hold” rating given on Tuesday, November 10 by Cantor Fitzgerald. The stock of FactSet Research Systems Inc. (NYSE:FDS) earned “Neutral” rating by Macquarie Research on Friday, August 26. UBS downgraded the shares of FDS in report on Thursday, March 10 to “Sell” rating.

Among 18 analysts covering SAGE Therapeutics (NASDAQ:SAGE), 16 have Buy rating, 0 Sell and 2 Hold. Therefore 89% are positive. SAGE Therapeutics had 56 analyst reports since September 3, 2015 according to SRatingsIntel. Chardan Capital Markets initiated the shares of SAGE in report on Tuesday, May 24 with “Sell” rating. The rating was maintained by BMO Capital Markets on Thursday, September 14 with “Outperform”. The stock of Sage Therapeutics, Inc. (NASDAQ:SAGE) earned “Buy” rating by Stifel Nicolaus on Tuesday, September 12. The stock of Sage Therapeutics, Inc. (NASDAQ:SAGE) earned “Neutral” rating by H.C. Wainwright on Wednesday, February 22. Lake Street initiated it with “Buy” rating and $90 target in Friday, March 11 report. The stock of Sage Therapeutics, Inc. (NASDAQ:SAGE) earned “Buy” rating by BMO Capital Markets on Thursday, November 9. Needham maintained Sage Therapeutics, Inc. (NASDAQ:SAGE) rating on Tuesday, September 12. Needham has “Buy” rating and $86.0 target. The stock of Sage Therapeutics, Inc. (NASDAQ:SAGE) earned “Outperform” rating by Raymond James on Tuesday, September 13. The stock of Sage Therapeutics, Inc. (NASDAQ:SAGE) has “Buy” rating given on Thursday, November 9 by Cowen & Co. The stock of Sage Therapeutics, Inc. (NASDAQ:SAGE) earned “Buy” rating by Stifel Nicolaus on Thursday, December 7.

Since December 14, 2017, it had 0 insider buys, and 4 insider sales for $37.32 million activity. PAUL STEVEN M had sold 58,139 shares worth $10.00M on Tuesday, March 6. Kanes Stephen sold $7.80M worth of stock. 59,000 shares valued at $9.96 million were sold by STARR KEVIN P on Tuesday, April 17.

Investors sentiment increased to 1.49 in Q4 2017. Its up 0.28, from 1.21 in 2017Q3. It is positive, as 27 investors sold SAGE shares while 56 reduced holdings. 63 funds opened positions while 61 raised stakes. 41.45 million shares or 7.53% more from 38.55 million shares in 2017Q3 were reported. 6,431 were accumulated by Essex Investment Ltd. Emerald Mutual Fund Advisers stated it has 133,323 shares. Nuveen Asset Mngmt Limited Liability Company accumulated 8,814 shares. Point72 Asset Mngmt Ltd Partnership stated it has 0.01% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Atika Management Ltd Liability holds 6,000 shares. Laurion Cap Management LP holds 0.03% or 35,052 shares. Voloridge Inv Mgmt Limited Liability Corporation accumulated 53,908 shares or 0.19% of the stock. 21,222 were reported by Columbus Circle. Moreover, World Asset Mngmt has 0.01% invested in Sage Therapeutics, Inc. (NASDAQ:SAGE). New Leaf Venture Ptnrs Ltd Company owns 25,000 shares. Public Employees Retirement Association Of Colorado reported 3,072 shares. Ubs Asset Mngmt Americas stated it has 175,630 shares. California Public Employees Retirement, a California-based fund reported 74,660 shares. Emerald Advisers Pa accumulated 168,785 shares. Lord Abbett & Ltd Liability Corp stated it has 671,535 shares or 0.31% of all its holdings.

Sage Therapeutics, Inc. (NASDAQ:SAGE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: